LIANBIO-ADR (LIAN) Stock Analyst Ratings

NASDAQ:LIAN - Nasdaq - US53000N1081 - ADR - Currency: USD

0.319 -0.03 (-8.28%)

After market: 0.32 +0 (+0.31%)

Buy % Consensus

ChartMill assigns a Buy % Consensus number of 43% to LIAN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 3.98. This target is 1147.02% above the current price.

LIAN was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about LIAN.

In the previous month the buy percentage consensus was at a similar level.

LIAN was analyzed by 6 analysts. More opinions would make the average more meaningful.

Price

Low

Median

Mean

High

0.32

3.03

3.98

5.04

849.84%

1,147.02%

1,479.94%

Up and Down Grades

Date	Firm	Action	Rating
2024-01-03	B of A Securities	Downgrade	Buy -> Underperform
2023-12-22	Jefferies	Downgrade	Buy -> Hold
2023-10-25	Raymond James	Maintains	Outperform -> Outperform
2022-10-14	Raymond James	Maintains	Outperform
2021-11-26	Goldman Sachs	Initiate	Neutral
2021-11-26	Jefferies	Initiate	Buy
2021-11-24	Raymond James	Initiate	Outperform